Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

Advancements in AI, multi-omics, and genome editing are transforming life sciences and biotechnology, addressing new ...

AI is going to reproduce human intelligence. AI will eliminate disease. AI is the single biggest, most important invention in human history. You've likely heard it all—but probably none of these ...

Type 2 diabetes (T2D) is a major chronic metabolic disease worldwide and is especially prevalent in older adults. Although many synthetic drugs are ...

This year, hype around AI really exploded, and so did concerns about AI’s environmental footprint. We also saw some surprising biotech developments. It's been a busy and productive year here at MIT ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

The molecular understanding of brain tumors has undergone a profound transformation in recent years. Advances in genomics, ...

Illumina is building the most comprehensive multiomic solutions in the industry, anchored on its world-class sequencing platforms for unmatched quality and scale. For research and pharma innovators, ...

A research team has uncovered key molecular insights into how the hybrid rice variety Liangyou 287 (LY287) achieves superior ...

The Global Cancer Biomarkers Market is projected to grow at a CAGR of 8.6% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that the market was ...